Lisata Therapeutics LSTA

Lisata Therapeutics, Inc. · Nasdaq · Pharmaceutical Preparations

$0.90-1.22%close on Nov. 20, 2026 · volume 109K · Yahoo Finance

Price, last 64 sessions

$1.00$1.50Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 20, 2026 · high $1.90 · low $0.90 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 12 →
  • 8-K/ANov. 19, 2026, 4:12 p.m. ETView on SEC.gov

    Financial statements and exhibits

  • 8-KNov. 19, 2026, 9:18 a.m. ETView on SEC.govOur explainer

    Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Other events · Financial statements and exhibits

    AI summary, unreviewedLisata Therapeutics announces one-for-fifteen reverse stock split effective November 23, 2026, cutting shares outstanding from about 10.8 million to about 0.7 million

  • 10-QNov. 13, 2026, 4:05 p.m. ETView on SEC.gov
  • 8-K/ANov. 12, 2026, 6:07 a.m. ETView on SEC.gov

    Financial statements and exhibits

  • 8-KNov. 9, 2026, 5:15 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Other events · Financial statements and exhibits

    AI summary, unreviewedLisata Therapeutics Annual Meeting Approves 2026 Equity Plan and Reverse Split Authority, But Series C Conversion Proposal Adjourned to November 30

  • 8-KOct. 14, 2026, 4:25 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Financial statements and exhibits

  • 8-KSept. 17, 2026, 9:27 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Unregistered sales of equity securities · Departure/appointment of directors or officers · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits

  • SCHEDULE 13GAug. 26, 2026, 1:02 p.m. ETView on SEC.gov